ES8703424A1 - Procedimiento para la obtencion de compuestos de amida - Google Patents

Procedimiento para la obtencion de compuestos de amida

Info

Publication number
ES8703424A1
ES8703424A1 ES550926A ES550926A ES8703424A1 ES 8703424 A1 ES8703424 A1 ES 8703424A1 ES 550926 A ES550926 A ES 550926A ES 550926 A ES550926 A ES 550926A ES 8703424 A1 ES8703424 A1 ES 8703424A1
Authority
ES
Spain
Prior art keywords
unsubstituted
carbocyclic
heterocyclic aryl
substituted lower
aryl radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550926A
Other languages
English (en)
Other versions
ES550926A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8703424A1 publication Critical patent/ES8703424A1/es
Publication of ES550926A0 publication Critical patent/ES550926A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE AMIDA. CONSISTENTE EN: HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) SEGUN EL METODO DE CARBODIIMIDA CON N,NK-DICILOHEXIL-CARBODIIMIDA EN PRESENCIA DE 1-HIDROXIBENZOTRIAZOL, PARA OBTENER LOS COMPUESTOS DE FORMULA GENERAL (I). SIENDO: N, 1, 2 O 3; AR, UN RESTO ARILO CARBOCICLICO O HETEROCICLICO; AC, EL RESTO ACILO DE UN ACIDO; Z, UN RESTO -OR7 O -NR8R9; R1, HIDROGENO, ALQUILO INFERIOR INSUSTITUIDO O SUSTITUIDO, UN RESTO ARILO U OTROS; R2 Y R3, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO INFERIOR, FORMILO U OTROS; R4, H O ALQUILO INFERIOR; R5 Y R6, INDEPENDIENTEMENTE, H, ALQUILO INFERIOR, O UN RESTO ARILO CARBOCICLICO O HETEROCICLICO; R7, R8 Y R9, H, ALQUILO O UN RESTO ARILO; RK4, RK5 Y RK6, LOS MISMOS SIGNIFICADOS QUE R4, R5 Y R6 PERO PUEDEN SER DISTINTOS QUE EN LA FORMULA (II); NK ES 0, 1 O 2; NL, 0, 1 O 2; Y RB, UN GRUPO CARBOXI. UTILIZABLES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
ES550926A 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida Expired ES8703424A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH615483 1983-11-16
CH342584 1984-07-13

Publications (2)

Publication Number Publication Date
ES8703424A1 true ES8703424A1 (es) 1987-02-16
ES550926A0 ES550926A0 (es) 1987-02-16

Family

ID=25692968

Family Applications (4)

Application Number Title Priority Date Filing Date
ES537646A Expired ES8706634A1 (es) 1983-11-16 1984-11-14 Procedimiento para la obtencion de compuestos de amida
ES550926A Expired ES8703424A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida
ES550927A Expired ES8703427A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida
ES550928A Expired ES8703428A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES537646A Expired ES8706634A1 (es) 1983-11-16 1984-11-14 Procedimiento para la obtencion de compuestos de amida

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES550927A Expired ES8703427A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida
ES550928A Expired ES8703428A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida

Country Status (13)

Country Link
EP (1) EP0145956A1 (es)
KR (1) KR850003713A (es)
AU (1) AU578633B2 (es)
DD (1) DD228547A5 (es)
DK (1) DK543084A (es)
ES (4) ES8706634A1 (es)
FI (1) FI844466L (es)
GR (1) GR80948B (es)
HU (1) HU193909B (es)
IL (1) IL73509A (es)
NO (1) NO844560L (es)
NZ (1) NZ210223A (es)
PT (1) PT79498B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
JPH0676405B2 (ja) * 1986-06-13 1994-09-28 日清製粉株式会社 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物
US4808603A (en) * 1985-08-14 1989-02-28 Ciba-Geigy Corporation 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and pharmaceutical compositions thereof
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
KR940005016B1 (ko) * 1990-11-30 1994-06-09 후지레비오 가부시끼가이샤 1,4-디히드로피리딘 유도체 및 그의 제조방법
DE59205565D1 (de) * 1991-10-07 1996-04-11 Hoechst Ag Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) * 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
CN107857712B (zh) * 2016-09-22 2022-09-09 烟台益诺依生物医药科技有限公司 (r)-3-甲基-2-(3-氧代酰胺基)正丁酸酯

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
DE3042769A1 (de) * 1980-11-13 1982-06-09 Bayer Ag, 5090 Leverkusen C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
FR2508446B1 (fr) * 1981-06-25 1986-05-02 Rhone Poulenc Agrochimie Herbicides a fonctions amide et ester derives de la pyridine ainsi que leur procede de preparation et leur application
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities

Also Published As

Publication number Publication date
ES550928A0 (es) 1987-02-16
PT79498B (en) 1987-01-13
NO844560L (no) 1985-05-20
DK543084D0 (da) 1984-11-15
AU3547484A (en) 1985-05-23
ES8703427A1 (es) 1987-02-16
ES550926A0 (es) 1987-02-16
EP0145956A1 (de) 1985-06-26
AU578633B2 (en) 1988-11-03
DD228547A5 (de) 1985-10-16
KR850003713A (ko) 1985-06-26
ES8703428A1 (es) 1987-02-16
HUT35645A (en) 1985-07-29
ES550927A0 (es) 1987-02-16
FI844466L (fi) 1985-05-17
HU193909B (en) 1987-12-28
ES8706634A1 (es) 1987-06-16
IL73509A (en) 1988-05-31
PT79498A (en) 1984-12-01
ES537646A0 (es) 1987-06-16
IL73509A0 (en) 1985-02-28
DK543084A (da) 1985-05-17
FI844466A0 (fi) 1984-11-14
GR80948B (en) 1985-03-01
NZ210223A (en) 1988-10-28

Similar Documents

Publication Publication Date Title
GR78508B (es)
ATE26263T1 (de) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine, verfahren zur herstellung derselben und ihre verwendung als heilmittel.
ES8405371A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8703428A1 (es) Procedimiento para la obtencion de compuestos de amida
ES8600243A1 (es) Procedimiento para la obtencion de compuestos de 2-hidroximetil-3-carbamoil-1,4-dihidropiridina
ES8503339A1 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
GR861778B (en) Method for preparing novel dihydro-2,3 benzofurane
ES8604543A1 (es) Procedimiento para la obtencion de derivados piperazinicos
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
ES8607980A1 (es) Procedimiento para la obtencion de muramilpeptidos
DK211283A (da) Benzothiazolinforbindelser
ES8308330A1 (es) "procedimiento para la preparacion de compuestos heterociclicos".
ES8401008A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES8601910A1 (es) Un procedimiento para preparar nuevos derivados amidinicos de 4-fenilimidazol sustituido en la posicion 2
ZA852359B (en) Enkephalinase inhibitors
ES8105981A1 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
GB1213285A (en) Substituted s-triazines
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
ES8704459A1 (es) Procedimiento para la obtencion de acemetacina.
EP0195374A3 (en) N-substituted 3,4-dihydropyrimidine derivatives, process for the production thereof and composition containing same for treating disorders of cardiovascular system
GR73137B (es)
NO870077D0 (no) Nye tyroninderivater.
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados